| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.48e-04 | 507 | 46 | 7 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.48e-04 | 507 | 46 | 7 | GO:0030695 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 4.41e-04 | 279 | 46 | 5 | GO:0005096 | |
| GeneOntologyCellularComponent | centriole | 4.65e-04 | 172 | 44 | 4 | GO:0005814 | |
| GeneOntologyCellularComponent | axon | 4.78e-04 | 891 | 44 | 8 | GO:0030424 | |
| MousePheno | increased neuron apoptosis | 2.29e-05 | 143 | 34 | 5 | MP:0003203 | |
| Domain | RA | 8.82e-07 | 31 | 45 | 4 | SM00314 | |
| Domain | RA | 1.83e-06 | 37 | 45 | 4 | PS50200 | |
| Domain | RA_dom | 2.52e-06 | 40 | 45 | 4 | IPR000159 | |
| Domain | RA | 8.83e-05 | 36 | 45 | 3 | PF00788 | |
| Domain | RasGAP | 5.07e-04 | 14 | 45 | 2 | SM00323 | |
| Domain | RasGAP_CS | 5.07e-04 | 14 | 45 | 2 | IPR023152 | |
| Domain | RAS_GTPASE_ACTIV_2 | 5.84e-04 | 15 | 45 | 2 | PS50018 | |
| Domain | RasGAP | 5.84e-04 | 15 | 45 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 5.84e-04 | 15 | 45 | 2 | PS00509 | |
| Domain | - | 6.67e-04 | 16 | 45 | 2 | 1.10.506.10 | |
| Domain | RasGAP_dom | 8.47e-04 | 18 | 45 | 2 | IPR001936 | |
| Domain | Rho_GTPase_activation_prot | 1.24e-03 | 88 | 45 | 3 | IPR008936 | |
| Domain | AT_hook | 1.92e-03 | 27 | 45 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.92e-03 | 27 | 45 | 2 | IPR017956 | |
| Domain | RasGEF | 2.37e-03 | 30 | 45 | 2 | PF00617 | |
| Domain | - | 2.37e-03 | 30 | 45 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 2.37e-03 | 30 | 45 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 2.37e-03 | 30 | 45 | 2 | IPR001895 | |
| Domain | RasGEF | 2.37e-03 | 30 | 45 | 2 | SM00147 | |
| Domain | C2 | 4.83e-03 | 142 | 45 | 3 | PS50004 | |
| Domain | - | 5.42e-03 | 148 | 45 | 3 | 2.60.40.150 | |
| Domain | C2_dom | 7.20e-03 | 164 | 45 | 3 | IPR000008 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 1.67e-05 | 144 | 32 | 5 | M39691 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 6.94e-05 | 318 | 32 | 6 | MM15278 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 8.10e-05 | 327 | 32 | 6 | M27565 | |
| Pathway | BIOCARTA_BTG2_PATHWAY | 2.22e-04 | 10 | 32 | 2 | MM1540 | |
| Pathway | BIOCARTA_BTG2_PATHWAY | 2.71e-04 | 11 | 32 | 2 | M22014 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 8621380 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 16091739 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26677227 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 11121408 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.79e-06 | 1105 | 47 | 10 | 35748872 | |
| Pubmed | SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. | 5.36e-06 | 3 | 47 | 2 | 9581761 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 21825075 | ||
| Pubmed | Functional interaction between human topoisomerase IIalpha and retinoblastoma protein. | 5.36e-06 | 3 | 47 | 2 | 10393912 | |
| Pubmed | Germline RET variants underlie a subset of paediatric osteosarcoma. | 5.36e-06 | 3 | 47 | 2 | 32179705 | |
| Pubmed | DNA topoisomerases participate in fragility of the oncogene RET. | 5.36e-06 | 3 | 47 | 2 | 24040417 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDCD11 NSUN5 DPYSL2 RAB3GAP1 RAB34 SRCAP RB1 MYO9B THRAP3 TOP2A | 1.07e-05 | 1353 | 47 | 10 | 29467282 |
| Pubmed | TNF-α/TNFR1 signaling is required for the development and function of primary nociceptors. | 1.07e-05 | 4 | 47 | 2 | 24811380 | |
| Pubmed | HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha. | 1.78e-05 | 5 | 47 | 2 | 19223331 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 19273906 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 1376319 | ||
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 5.87e-05 | 307 | 47 | 5 | 37499664 | |
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 24752460 | ||
| Pubmed | 7.94e-05 | 533 | 47 | 6 | 25544563 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 10629055 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 21151121 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 26123588 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.21e-04 | 358 | 47 | 5 | 32460013 | |
| Pubmed | 1.61e-04 | 14 | 47 | 2 | 19755105 | ||
| Pubmed | 2.03e-04 | 1215 | 47 | 8 | 15146197 | ||
| Pubmed | 2.40e-04 | 17 | 47 | 2 | 26542706 | ||
| Pubmed | RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation. | 2.70e-04 | 18 | 47 | 2 | 27558965 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.82e-04 | 430 | 47 | 5 | 35044719 | |
| Pubmed | 3.01e-04 | 19 | 47 | 2 | 18329113 | ||
| Pubmed | 3.34e-04 | 20 | 47 | 2 | 18162579 | ||
| Pubmed | 4.84e-04 | 24 | 47 | 2 | 17553423 | ||
| Pubmed | SALM4 suppresses excitatory synapse development by cis-inhibiting trans-synaptic SALM3-LAR adhesion. | 5.26e-04 | 25 | 47 | 2 | 27480238 | |
| Pubmed | Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. | 5.26e-04 | 25 | 47 | 2 | 8889551 | |
| Pubmed | 5.27e-04 | 493 | 47 | 5 | 15368895 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.31e-04 | 759 | 47 | 6 | 35915203 | |
| Pubmed | Molecular profiles of mitogen activated protein kinase signaling pathways in orofacial development. | 5.69e-04 | 26 | 47 | 2 | 17177285 | |
| Pubmed | 5.69e-04 | 26 | 47 | 2 | 11931757 | ||
| Pubmed | 5.81e-04 | 120 | 47 | 3 | 21697133 | ||
| Pubmed | 7.09e-04 | 29 | 47 | 2 | 18239623 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 7.32e-04 | 807 | 47 | 6 | 22681889 | |
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 7.50e-04 | 303 | 47 | 4 | 25056061 | |
| Pubmed | 8.13e-04 | 1497 | 47 | 8 | 31527615 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 8.46e-04 | 313 | 47 | 4 | 38270169 | |
| Pubmed | 8.55e-04 | 549 | 47 | 5 | 38280479 | ||
| Pubmed | Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein. | 8.64e-04 | 32 | 47 | 2 | 28656962 | |
| Pubmed | 9.23e-04 | 844 | 47 | 6 | 25963833 | ||
| Pubmed | 1.02e-03 | 329 | 47 | 4 | 17474147 | ||
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 1.03e-03 | 146 | 47 | 3 | 20686565 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 1.09e-03 | 1203 | 47 | 7 | 29180619 | |
| Pubmed | Gene content of the 750-kb critical region for mouse embryonic ectoderm lethal tcl-w5. | 1.09e-03 | 36 | 47 | 2 | 15112104 | |
| Pubmed | Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. | 1.16e-03 | 37 | 47 | 2 | 18498735 | |
| Pubmed | Heart neurons use clock genes to control myocyte proliferation. | 1.16e-03 | 37 | 47 | 2 | 34851661 | |
| Interaction | MAPK9 interactions | 4.47e-06 | 186 | 47 | 6 | int:MAPK9 | |
| Cytoband | 19q13.33 | 1.80e-04 | 106 | 47 | 3 | 19q13.33 | |
| Cytoband | Xq13.1 | 1.12e-03 | 48 | 47 | 2 | Xq13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.31e-03 | 797 | 47 | 5 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 1.49e-03 | 219 | 47 | 3 | chr7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 1.75e-03 | 503 | 47 | 4 | chr6p21 | |
| Cytoband | 6p21.3 | 2.17e-03 | 250 | 47 | 3 | 6p21.3 | |
| Cytoband | 7q22.1 | 6.04e-03 | 113 | 47 | 2 | 7q22.1 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.11e-04 | 10 | 29 | 2 | 830 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | FRS3 NSUN5 LILRA3 PPP1R35 RASAL3 MBD6 SLC12A9 PTCD1 MYO9B NDST2 | 3.72e-06 | 905 | 47 | 10 | M40865 |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 2.58e-05 | 195 | 47 | 5 | M7926 | |
| Coexpression | GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP | 2.58e-05 | 195 | 47 | 5 | M7125 | |
| Coexpression | GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN | 2.91e-05 | 200 | 47 | 5 | M3377 | |
| ToppCell | Control-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.86e-06 | 120 | 47 | 4 | 695dab6b01ad2c33cdcaf92bb9996ff2899ef77e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-05 | 163 | 47 | 4 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-05 | 163 | 47 | 4 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Th17|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.95e-05 | 168 | 47 | 4 | 97bf074b91c9ae0064edc31fa4a2658ffdcfefa3 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 173 | 47 | 4 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 176 | 47 | 4 | 867936a20f73f638055c19c8d88834aa2cc657cf | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 176 | 47 | 4 | 8e89471f838ea81235256cc2470f1c12c9b75f8a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-05 | 176 | 47 | 4 | 183ba1aa5cf594b88ec08e0e41241668b51256a9 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 182 | 47 | 4 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-05 | 183 | 47 | 4 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.17e-05 | 194 | 47 | 4 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.17e-05 | 194 | 47 | 4 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | (08)_PNEC|World / shred by cell type and Timepoint | 5.38e-05 | 196 | 47 | 4 | 2ee37155c03cd5009427a4bffe6c80ed2ac6939e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.49e-05 | 197 | 47 | 4 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-GABAergic_neurons|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 5.49e-05 | 197 | 47 | 4 | e1a80c1aa7f7e83f5d19a40fe37db5c5a6c25685 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.49e-05 | 197 | 47 | 4 | 52246d1354c4e2b13d48c878643edf843d2b50d2 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.71e-05 | 199 | 47 | 4 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.71e-05 | 199 | 47 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.71e-05 | 199 | 47 | 4 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.82e-05 | 200 | 47 | 4 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 200 | 47 | 4 | d39bf03817b76c9dfcbcd868341b51bb8601ea9b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 200 | 47 | 4 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-Dividing_AT2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 200 | 47 | 4 | befc25cbcbac2c02e5fd33d6e78e59979050090c | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 6.49e-07 | 49 | 41 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Adrenocortical carcinoma | 2.84e-04 | 18 | 41 | 2 | C0206686 | |
| Disease | cancer (implicated_via_orthology) | 5.17e-04 | 268 | 41 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | breast cancer, lung cancer | 5.54e-04 | 25 | 41 | 2 | MONDO_0007254, MONDO_0008903 | |
| Disease | azoospermia (implicated_via_orthology) | 6.47e-04 | 27 | 41 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.24e-03 | 152 | 41 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | ductal carcinoma in situ (is_marker_for) | 1.35e-03 | 39 | 41 | 2 | DOID:0060074 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTDFFARRRPGPPRI | 6 | Q9H211 | |
| PRPQFRGVRRISPIT | 326 | Q9HCE9 | |
| TAVIPINGSPRTPRR | 241 | P06400 | |
| RPLRRPRPVQRTQSV | 806 | Q86YV0 | |
| GREFILRTTVPRPAP | 936 | Q15042 | |
| LRRPVTVPAGIRPQS | 246 | Q8WWW0 | |
| FARRGVRRPNPSVPS | 96 | Q8N7Y1 | |
| SRPGPASQLPRFVRV | 126 | Q96P11 | |
| QRRRPTRPLEVGAPF | 421 | P23352 | |
| PSQRRPRRPPTVFRL | 361 | Q96DN6 | |
| RLRSPRVLFSTQPPR | 81 | P01138 | |
| PRRTTQRIVAPPGGR | 551 | Q16555 | |
| GERPQLVRRRPPTAR | 76 | Q96HB5 | |
| VRRVDVRPLPASPAR | 151 | Q9BQ89 | |
| SRRRNLPRPVLVRPG | 51 | Q9NUL7 | |
| FLRVLTGRIPPSTPR | 131 | Q92643 | |
| GRPPRPLVVRAVRSR | 21 | Q86YD1 | |
| SPVRIPFMQRPARRG | 1926 | O95996 | |
| FPVPLTRRRGSPRVF | 386 | O43559 | |
| TPTQTVVRPAGFPRR | 51 | Q9NVV2 | |
| AGPVVRLVVRRRQPP | 206 | Q92796 | |
| GVPTIRSDIPAPRIR | 721 | Q8N7U6 | |
| IGSPIPEPRQRSRLL | 641 | Q86YS7 | |
| QIRARPFLSVRPGPT | 321 | Q8N6C8 | |
| RVRRVAPRFSIPPSS | 226 | P10586 | |
| NLPTAPPRRRVSERV | 381 | Q8TB24 | |
| SPGVRRKRVSPVPFQ | 266 | Q13233 | |
| RQVRRRPPVLFRLTP | 541 | Q5HYW3 | |
| GEVTIRPLRPPQRAR | 316 | O15211 | |
| PRVPRSRRQVLPGTA | 71 | Q8IYJ0 | |
| RRQVRFRLTPPSPVR | 76 | Q8TAP8 | |
| RGRPRIRPLEVPTTA | 1171 | Q9ULL5 | |
| TPRRRPGPRRLVGTT | 3186 | Q6ZRS2 | |
| PREFVLRPAPQGRTV | 291 | O00294 | |
| RPIFLQPGRPLTRLS | 346 | Q14690 | |
| QSVVVRRRSPRPSPV | 256 | Q9Y2W1 | |
| PTVSPVTRPRVVARG | 101 | P0C879 | |
| RQSERPRPQPVVLRG | 736 | Q96PV0 | |
| RGFRALPITQPTPRG | 81 | Q9BW04 | |
| EVFRVALRPRPGRPT | 61 | Q9BRG2 | |
| FVAVGPRDIRLTPRP | 211 | Q9BXP2 | |
| ALVRPRGRAVPPFVF | 31 | O75896 | |
| RGPPRQPVESARSFR | 396 | Q9UJ04 | |
| AVPGPVLRRARLPTV | 251 | P52849 | |
| RPSFRIRENRPPGTF | 171 | P07949 | |
| LPSPRGQRVIPRITI | 1211 | P11388 | |
| ATVLQPPVSRQRPRR | 351 | O75127 | |
| GQVTRIPPVRTVRRA | 61 | Q6ZSA8 | |
| VGSPRPRVIVGTIRP | 11 | P0DI83 | |
| PRPRVIFGTPRARVI | 61 | P0DI83 | |
| AAPPRRRPSSFVTVR | 2041 | Q13459 |